Medacta International Overview
- Year Founded
-
1999
- Status
-
Public
- Employees
-
2,273
- Stock Symbol
-
MOVE
- Investments
-
4
- Share Price
-
$129.18
- (As of Friday Closing)
Medacta International General Information
Description
Medacta Group SA is involved in developing, manufacturing, and distributing orthopedic and neurosurgical medical devices. It specializes in the design, production, and distribution of personalized and sustainable solutions for joint replacement, sports medicine, and spine surgery. Medacta's product portfolio includes hip, knee, shoulder, and spine replacement solutions, along with a comprehensive range of sports medicine. Its products and surgical techniques are supported by an extensive program of surgeon education and engagement initiatives, enabling its offerings to be effective for the patient and surgeon. Geographically, the company derives maximum revenue from EMEA (which includes Europe, Middle East and Africa), followed by North America, Asia-Pacific, and the Latin America markets.
Contact Information
Website
www.medacta.comCorporate Office
- Strada Regina
- 6874 Castel San Pietro
- Switzerland
Corporate Office
- Strada Regina
- 6874 Castel San Pietro
- Switzerland
Medacta International Stock Performance
As of 13-Nov-2026, Medacta International’s stock price is $129.18. Its current market cap is $2.58B with 19.9M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $129.18 | $130.47 | $127.98 - $225.68 | $2.58B | 19.9M | 33.6K | $4.53 |
Medacta International Financials Summary
As of 30-Jun-2026, Medacta International has a trailing 12-month revenue of $826M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 3,613,968 | 3,965,439 | 2,382,449 | 2,977,945 |
| Revenue | 825,724 | 771,361 | 639,066 | 552,700 |
| EBITDA | 212,825 | 221,148 | 173,451 | 133,208 |
| Net Income | 90,152 | 107,679 | 78,870 | 51,249 |
| Total Assets | 1,150,669 | 1,077,882 | 824,317 | 769,216 |
| Total Debt | 362,412 | 306,295 | 250,994 | 223,268 |
Medacta International Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Medacta International Comparisons
Industry
Financing
Details
Medacta International Competitors (14)
One of Medacta International’s 14 competitors is Orthofix Medical, a Formerly PE-Backed company based in Lewisville, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Orthofix Medical | Formerly PE-Backed | Lewisville, TX | ||||
| Zimmer Biomet Holdings | Corporation | Warsaw, IN | ||||
| Medtronic | Corporation | Minneapolis, MN | ||||
| Spine Wave | Venture Capital-Backed | Shelton, CT | ||||
| Orchid Orthopedic Solutions | Private Equity-Backed | Mason, MI |
Medacta International Patents
Medacta International Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026210268-A1 | Anchoring device for an orthopaedic prosthesis | Pending | 31-Mar-2025 | ||
| WO-2026120393-A1 | Equipment for tibio-femoral arthroplasty surgery | Pending | 06-Dec-2024 | ||
| WO-2026120397-A1 | Equipment for tibio-femoral arthroplasty surgery | Pending | 06-Dec-2024 | ||
| WO-2026093834-A1 | Tibial guide for arthroplastic surgery of a tibio-femoral joint and kit for arthroplastic surgery of a tibio-femoral joint | Pending | 28-Oct-2024 | ||
| WO-2026058092-A1 | Method for generating a kinematic alignment reference system | Pending | 10-Sep-2024 | A61B34/10 |
Medacta International Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Medacta International Acquisitions (4)
Medacta International’s most recent deal was a Merger/Acquisition with Parcus Medical for . The deal was made on 07-Mar-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Parcus Medical | 07-Mar-2025 | Merger/Acquisition | Therapeutic Devices | ||
| Levante Medica 2008 | 01-Jan-2022 | Merger/Acquisition | Other Devices and Supplies | ||
| Balgrist University Hospital | 01-Oct-2018 | Merger/Acquisition | Hospitals/Inpatient Services | ||
| Vivamed Medizinprodukte Vertriebs | 01-Jan-2017 | Merger/Acquisition | Distributors (Healthcare) |
Medacta International ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
29.11 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Medacta International Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Balgrist University Hospital | Zurich, Switzerland | 1912 |
Medacta International FAQs
-
When was Medacta International founded?
Medacta International was founded in 1999.
-
Where is Medacta International headquartered?
Medacta International is headquartered in Castel San Pietro, Switzerland.
-
What is the size of Medacta International?
Medacta International has 2,273 total employees.
-
What industry is Medacta International in?
Medacta International’s primary industry is Therapeutic Devices.
-
Is Medacta International a private or public company?
Medacta International is a Public company.
-
What is Medacta International’s stock symbol?
The ticker symbol for Medacta International is MOVE.
-
What is the current stock price of Medacta International?
As of 13-Nov-2026 the stock price of Medacta International is $129.18.
-
What is the current market cap of Medacta International?
The current market capitalization of Medacta International is $2.58B.
-
What is Medacta International’s current revenue?
The trailing twelve month revenue for Medacta International is $826M.
-
Who are Medacta International’s competitors?
Orthofix Medical, Zimmer Biomet Holdings, Medtronic, Spine Wave, and Orchid Orthopedic Solutions are some of the 14 competitors of Medacta International.
-
What is Medacta International’s annual earnings per share (EPS)?
Medacta International’s EPS for 12 months was $4.53.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
